You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 7, 2025

Details for Patent: 10,512,609


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,512,609 protect, and when does it expire?

Patent 10,512,609 protects SUNOSI and is included in one NDA.

This patent has twenty-one patent family members in eighteen countries.

Summary for Patent: 10,512,609
Title:Formulations of (R)-2-amino-3-phenylpropyl carbamate
Abstract: The present invention relates to immediate release formulations of (R)-2-amino-3-phenylpropyl carbamate and methods of using the same to treat disorders.
Inventor(s): Allphin; Clark Patrick (Seattle, WA), Walsh; Edwin Gerard (Contarf, IE)
Assignee: Jazz Pharmaceuticals Ireland Limited (Dublin, IE)
Application Number:16/225,890
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,512,609
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,512,609

Introduction

When analyzing a patent, particularly one like United States Patent 10,512,609, it is crucial to delve into the scope and claims of the patent, as well as the broader patent landscape. This analysis helps in understanding the patent's validity, potential for infringement, and its position within the intellectual property ecosystem.

Patent Overview

United States Patent 10,512,609 is part of a larger portfolio of patents, often associated with pharmaceutical or medical inventions. To provide a detailed analysis, we need to consider several key aspects:

Claim Scope and Construction

Importance of Claim Scope

The scope of a patent claim is critical in determining the extent of protection it offers. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate due to the abstract idea exception or failure to meet the written description requirement[5].

Claim Length and Count

Research indicates that narrower claims, measured by independent claim length and count, are associated with a higher probability of grant and a shorter examination process. This suggests that the claims in US Patent 10,512,609 should be carefully crafted to avoid being overly broad, which could lead to invalidation[3].

Patent Claims Analysis

Specificity and Embodiments

The claims in a US patent application must be anchored to the embodiments disclosed in the specification. For US Patent 10,512,609, the claims should be specific enough to cover the invention but not so broad that they encompass abstract ideas or fail to meet the written description requirement. This balance is crucial for maintaining the patent's validity[5].

Prior Art and Technical Field

The technical field in which the patent is filed can significantly impact the claim scope. In fields with extensive prior art, broader claims are more likely to be rejected. Therefore, understanding the prior art landscape and the specific technical field is essential for drafting and maintaining valid claims[5].

Patent Landscape and Trends

Global and US Trends

The USPTO has seen a significant increase in patent applications and grants over the past few decades. In 2018, the USPTO awarded 309,000 utility patents, with businesses receiving the majority of these patents. This trend indicates a growing importance of intellectual property protection, especially in fields like pharmaceuticals and medical devices[4].

Technology Areas

Patents granted by the USPTO are classified under various technological fields. For US Patent 10,512,609, understanding the specific technology area (e.g., pharmaceuticals, medical devices) can provide insights into the competitive landscape and the potential for future innovations and challenges[4].

Litigation and Infringement

Recent Litigation Examples

Patents like US Patent 10,512,609 are often involved in litigation, particularly in the pharmaceutical sector. For instance, the litigation between Axsome and Hetero over several patents, including those related to solriamfetol oral tablets, highlights the importance of patent validity and infringement claims. Ensuring that the claims of US Patent 10,512,609 are valid and not infringed upon is crucial for maintaining its value[2].

Search and Analysis Tools

USPTO Resources

The USPTO provides several tools for searching and analyzing patents, including the Global Dossier, Public Search Facility, and Patent and Trademark Resource Centers (PTRCs). These resources can help in identifying related applications, prior art, and office actions, which are essential for understanding the scope and claims of US Patent 10,512,609[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from participating IP offices, allowing for a comprehensive view of prior art citations. This tool can be invaluable in assessing the validity and scope of US Patent 10,512,609 by identifying relevant prior art cited by multiple offices[1].

Conclusion

Analyzing the scope and claims of US Patent 10,512,609 involves a multifaceted approach that considers the claim construction, prior art, technical field, and broader patent landscape. Ensuring that the claims are neither too broad nor too narrow, and are well-supported by the specification, is crucial for maintaining the patent's validity and value.

Key Takeaways

  • Claim Scope: The scope of the claims should be balanced to avoid being overly broad or too narrow.
  • Prior Art: Understanding the prior art in the technical field is essential for drafting valid claims.
  • Technical Field: The specific technology area impacts the claim scope and the competitive landscape.
  • Litigation: Ensuring the patent's validity is crucial in litigation scenarios.
  • USPTO Resources: Utilizing USPTO tools like the Global Dossier and CCD can provide comprehensive insights into the patent's scope and claims.

FAQs

Q: What is the importance of claim scope in a patent application? A: The claim scope determines the extent of protection offered by the patent. A balanced scope that is neither too broad nor too narrow is crucial for maintaining the patent's validity.

Q: How does prior art impact the claim scope of a patent? A: Prior art can make it more difficult to get broader claims allowed, especially in technical fields with extensive prior art.

Q: What tools does the USPTO provide for searching and analyzing patents? A: The USPTO provides tools such as the Global Dossier, Public Search Facility, and Patent and Trademark Resource Centers (PTRCs) for searching and analyzing patents.

Q: Why is it important to avoid overly broad claims in a patent application? A: Overly broad claims are easier to invalidate due to the abstract idea exception or failure to meet the written description requirement.

Q: How does the technical field impact the claim scope of a patent? A: The technical field can influence the claim scope, with fields having extensive prior art making it harder to get broader claims allowed.

Sources

  1. USPTO: Search for patents - USPTO
  2. Insight.RPXCorp: Charles M. Lizza William C. Baton Sarah A. Sullivan Alexander L ...
  3. SSRN: Patent Claims and Patent Scope
  4. NCSES: Invention: U.S. and Comparative Global Trends
  5. Rimon Law: The Importance of Getting the Claim Scope Right in a US Patent Application

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,512,609

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Axsome Malta SUNOSI solriamfetol hydrochloride TABLET;ORAL 211230-001 Jun 17, 2019 RX Yes No ⤷  Try for Free ⤷  Try for Free TO IMPROVE WAKEFULNESS IN ADULT PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY OR OBSTRUCTIVE SLEEP APNEA (OSA) ⤷  Try for Free
Axsome Malta SUNOSI solriamfetol hydrochloride TABLET;ORAL 211230-002 Jun 17, 2019 RX Yes Yes ⤷  Try for Free ⤷  Try for Free TO IMPROVE WAKEFULNESS IN ADULT PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY OR OBSTRUCTIVE SLEEP APNEA (OSA) ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,512,609

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2017324855 ⤷  Try for Free
Canada 3036068 ⤷  Try for Free
Chile 2019000571 ⤷  Try for Free
China 109906078 ⤷  Try for Free
Denmark 3509581 ⤷  Try for Free
European Patent Office 3509581 ⤷  Try for Free
Spain 2937795 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.